ES2052507T3 - Peptido, proceso para su sintesis, compuesto farmaceutico que lo contiene y utilizacion del mismo. - Google Patents

Peptido, proceso para su sintesis, compuesto farmaceutico que lo contiene y utilizacion del mismo.

Info

Publication number
ES2052507T3
ES2052507T3 ES87105570T ES87105570T ES2052507T3 ES 2052507 T3 ES2052507 T3 ES 2052507T3 ES 87105570 T ES87105570 T ES 87105570T ES 87105570 T ES87105570 T ES 87105570T ES 2052507 T3 ES2052507 T3 ES 2052507T3
Authority
ES
Spain
Prior art keywords
lys
leu
arg
peptido
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87105570T
Other languages
English (en)
Inventor
Osamu Ito
Shinro Tachibana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ES2052507T3 publication Critical patent/ES2052507T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/17—Vasoactive intestinal peptides; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION SE REFIERE A UN PEPTIDO QUE TIENE LA SIGUIENTE ESTRUCTURA:HIS-SER-ASP-ALA-VAL-PHE-THR-ASP-ASNTYR-THR-ARG-LEU-ARG-LYS-GLN-X-ALA-VAL-LYS-TYR-LEU-ASN-SERILE-LEU-ASN-GLY-Y, EN LA QUE X ES MET O LEU; E Y ES OH, LYS-OH, ARG-OH, LYS-ARG-OH O LYS-NH2 CUANDO X ES MET, O Y ES LYS-NH2, LYS-OH, O LYS-ARG-OH CUANDO X S LEU), A UN PROCEDIMIENTO PARA SINTETIZARLO, UNA COMPOSICION FARMACEUTICA QUE LO CONTIENE Y A SU EMPLEO EN LA PREPARACION DE UN MEDICAMENTO QUE TIENE ACTIVIDAD BRONCODILATADORA E HIPOTENSORA.
ES87105570T 1986-04-17 1987-04-15 Peptido, proceso para su sintesis, compuesto farmaceutico que lo contiene y utilizacion del mismo. Expired - Lifetime ES2052507T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61086987A JPS62246595A (ja) 1986-04-17 1986-04-17 気菅支拡張作用・降圧作用ペプタイド

Publications (1)

Publication Number Publication Date
ES2052507T3 true ES2052507T3 (es) 1994-07-16

Family

ID=13902213

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87105570T Expired - Lifetime ES2052507T3 (es) 1986-04-17 1987-04-15 Peptido, proceso para su sintesis, compuesto farmaceutico que lo contiene y utilizacion del mismo.

Country Status (10)

Country Link
US (2) US4757133A (es)
EP (1) EP0241926B1 (es)
JP (1) JPS62246595A (es)
AT (1) ATE84048T1 (es)
CA (1) CA1288894C (es)
DE (1) DE3783257T2 (es)
DK (1) DK193887A (es)
ES (1) ES2052507T3 (es)
GR (1) GR3006718T3 (es)
NO (1) NO871574L (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939224A (en) * 1987-02-26 1990-07-03 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
SE8702520D0 (sv) * 1987-06-16 1987-06-16 Kabigen Ab Mammal intestine hormone precursor
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
US5128242A (en) * 1989-06-19 1992-07-07 The Administrators Of The Tulane Educational Fund Hypothalamic polypeptides with adenylate cyclase stimulating activity
US5234907A (en) * 1989-06-30 1993-08-10 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
US5141924A (en) * 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs
US5236904A (en) * 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions
US5447912A (en) * 1989-09-18 1995-09-05 Senetek, Plc Erection-inducing methods and compositions
JPH04193896A (ja) * 1989-10-26 1992-07-13 Meiji Seika Kaisha Ltd 活性ペプチド
JPH03181499A (ja) * 1989-12-11 1991-08-07 Akira Kaji 新規ペプチド
ATE101619T1 (de) * 1990-06-26 1994-03-15 Sanwa Kagaku Kenkyusho Co Vip-analogen und ihre verwendung.
JPH05238950A (ja) * 1991-04-22 1993-09-17 Sanwa Kagaku Kenkyusho Co Ltd 易吸収性ｖｉｐ製剤
US5958881A (en) * 1991-04-25 1999-09-28 Korman; Louis Y. Composition containing VIP for injection and a method of enhancing visualization of tissues during medical procedures
US5623050A (en) * 1991-08-22 1997-04-22 Takeda Chemical Industries, Ltd. Stable polypeptides having c-AMP production enhancing activity and the use thereof
US5998368A (en) * 1991-10-31 1999-12-07 Yeda Research And Development Co. Ltd. Derivatives of structurally modified VIP and pharmaceutical compositions containing them
US5681816A (en) * 1992-04-24 1997-10-28 Korman; Louis Y. Method of inducing temporary paralysis of the gastrointestinal tract during medical procedure
US5252747A (en) * 1992-09-11 1993-10-12 Abbott Laboratories Chiral quinolone intermediates
AU682638B2 (en) * 1995-06-09 1997-10-09 ILS, Inc. Peptide, bronchodilator and blood flow ameliorant
AU2003284428B2 (en) * 2002-11-27 2010-08-26 Ils Inc. Peptides and medicinal compositions containing the same
US7595294B2 (en) * 2004-10-08 2009-09-29 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide pharmaceuticals
US20070293429A1 (en) * 2004-10-08 2007-12-20 Therapei Pharmaceuticals, Inc. Vasoactive Intestinal Polypeptide Compositions
US20090170775A1 (en) * 2004-10-08 2009-07-02 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide compositions
WO2006042152A2 (en) * 2004-10-08 2006-04-20 Forbes Medi-Tech (Research) Inc. Vasoactive intestinal polypeptide pharmaceuticals
US20080214440A1 (en) * 2004-10-08 2008-09-04 Forbes Medi-Tech (Research), Inc. Vasoactive intestinal polypeptide compositions
WO2008003612A2 (en) * 2006-07-06 2008-01-10 F. Hoffmann-La Roche Ag Analogs of vasoactive intestinal peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880826A (en) * 1971-09-17 1975-04-29 Sami I Said Vasoactive intestinal peptide
US3862927A (en) * 1973-02-26 1975-01-28 Sami I Said Process for preparation of vasoactive intestinal peptide
US4016258A (en) * 1975-08-05 1977-04-05 Said Sami I Vasoactive intestinal peptide from fowl
US4605641A (en) * 1984-10-09 1986-08-12 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs

Also Published As

Publication number Publication date
DE3783257D1 (de) 1993-02-11
CA1288894C (en) 1991-09-10
GR3006718T3 (es) 1993-06-30
DE3783257T2 (de) 1993-05-13
DK193887A (da) 1987-10-18
US4757133A (en) 1988-07-12
DK193887D0 (da) 1987-04-14
EP0241926A3 (en) 1989-03-08
US4822774A (en) 1989-04-18
JPS62246595A (ja) 1987-10-27
EP0241926B1 (en) 1992-12-30
ATE84048T1 (de) 1993-01-15
NO871574D0 (no) 1987-04-14
EP0241926A2 (en) 1987-10-21
NO871574L (no) 1987-10-19

Similar Documents

Publication Publication Date Title
ES2052507T3 (es) Peptido, proceso para su sintesis, compuesto farmaceutico que lo contiene y utilizacion del mismo.
DE69319440D1 (de) Herstellung von pharmazeutischen zusammensetzungen, die calcitonin enthalten
DE3586206D1 (de) Metoprololsuccinat und dieses enthaltende pharmazeutische zusammensetzung.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
MY101784A (en) Novel pharmacological compounds
IL77430A (en) 3-alkyl-and 3,8-dialkyl-6-thioxanthine and pharmaceutical compositions containing them
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
HU895335D0 (en) Process for the preparation of spiro-isoquinoline-pyrrolidine-tetrones and analogs thereof and pharmaceutical compositions containing said compounds
ZA852391B (en) Substituted benzopyrans,processes for their preparation,and their use in medicaments
DE3785046A1 (es)
IL84168A0 (en) Human factor viii-c analogs,process for the preparation thereof and pharmaceutical compositions containing the same
NO893062D0 (no) Anvendelse av isokinolinforbindelser, saerlig i inhalasjonspreparater.
HUT44804A (en) Process for producing new peptide antibiotica and pharmaceutical compositions containing them as active components
NZ215480A (en) Polyprenyl compounds and compositions
AU1655388A (en) Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis
GEP20002271B (en) Bicyclic Tachykinins Antagonists, Pharmaceutical Composition on Its Basis and Their Use
ES2001290A6 (es) Procedimiento para aislar (+)-6-cloro-5,10-dihidro-5-(1-metil-4-piperidil)-acetil)-11h-dibenzo(b,e)-(1,4)-diazepin-11-ona"
IT8819731A0 (it) Composizioni farmaceutiche contenenti timosina alfa 1.
SE9000793D0 (sv) Sdk-peptider,foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem
TR25423A (tr) DAHA AKTIF TüRLERI BAKIMINDAN ZENGINLESTIRILMIS SIPERMETRIN VEYA SIFLUTRIN ISOMERLERININ KARISIMLARININ HAZIRLANMASI.
IL95245A0 (en) Pharmaceutical compositions containing a certain carbazolone for the treatment of bulimia
DE68914175D1 (de) Parfümgrundzusammenstellung enthaltendes 2-cyclohexylpropanal und Verfahren zur Herstellung dieser Verbindung.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
EP0154544A3 (en) Des-proline vasopressin antagonists

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 241926

Country of ref document: ES